http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
한국인(韓國人) 남자(男子) 30-40대(代)와 50-60대(代)의 사상체질별(四象體質別) 안면형태(顔面形態)에 관(關)한 비교(比較) 연구(硏究)
임규성,김상복,이준희,박계수,이수경,이의주,고병희,송일병,윤종현,Lim, Kyu-Seong,Kim, Sang-Bok,Lee, Jun-Hee,Park, Gye-Soo,Lee, Su-Kyung,Lee, Eui-Ju,Koh, Byung-Hee,Song, Il-Byung,Yun, Jong-Hyun 사상체질의학회 2000 사상체질의학회지 Vol.12 No.2
1. Background and Purpose The faces of human being change as they grow older. We could know the characters of the each ages, through the facial comparison between the 30's, 40's and the 50's, 60's. As a conclusion, I carried out this Study because I thought that the errors of diagnosis would be reduced a lot through the standardization researches about the morphology of faces. 2. Objectives The object of this study is selected from the patients who were already diagnosed Sasang Constitutions at the department of Sasang Constitutional Medicine in Kyunghee Oriental Medical Center. The number of the patients were 69 men in 30's and 40's, and 74 men in 50's and 60's. 3. Method I took the photographs of front view and lateral view of the objectives by digital camera and obtained the 200 measure through the facial measurement program. I compared the measure of 50's and 60's with 30's and 40's by independant t-test. 4. Results 28 measures are different 30's and 40's with 50's and 60's in Soyangin, 31 measures in Soeumin, 40 measures in Taeumin. 5. Conclusion (1) Soyangin showed wider interpupillary distance in 30's and 40's than 50's and 60's. They also showed the large brow and cheek and their lips were thick and prominent and their ophyrion were prominent and their noses were wide and large and they showed wide bigonial breadth in 30's and 40's than 50's and 60's. (2) Soeumin showed the position of ears were higher and the brows were longer and larger in 30's and 40's than 50's and 60's. The width of both eyebrow were wider in 50's and 60's than 30's and 40's. The lower 2/3 portion of the face was longer and the shape of head was longer in vertical in 50's and 60's than 30's and 40's. (3) Taeumin showed the wider brow in 30's and 40's than 50's and 60's. The width of each eyes was wider and the width of cheek and face was larger, too. The ophyrion was prominent and the mouth was bigger and the face showed longer in 50's and 60's than 30's and 40's. (4) The upper 1/3 portion of the face was large in 30's and 40's and the lower 2/3 portion of the face showed large and long in 50's and 60's regardless Constitution.
상부 소화관 이물질의 내시경적 적출에 관한 임상적 고찰
임규성(Kyu Sung Rim),임현석(Hyun Suk Lim),신도영(Do Young Shin),임태희(Tae Hee Rim),김우중(Woo Joong Kim),박충기(Chung Ki Park) 대한소화기학회 1987 대한소화기학회지 Vol.19 No.1
N/A The clinical review was done on 9 cases with the foreign body in the upper gastrointestinal tract who visited and underwent endoscopic removal of foreign body at Kangnam Sacred Heart Hospital from Dec. 1980 to Aug. 1986. The results were as follow: 1) The age distribution varies from 3 months to 52 years of age, being most prevalent under 5 yrs of age. The ratio between male and female was 2:1, more prevalent in male. 2) The incidence of foreign body in order of frequency was coin, ring, peanut and keyring. Among 9 cases, 7 cases (77.8%) were lodged in the stomach and 2 cases (22.2%) were lodged in the esophagus. 3) In clinical symptom, asymptomatic cases (77.8%) were more common than symptomatic cases (22.2%). 7 cases of foreign body (77.8%) were removed out after 72 hours and 2 cases of foreign body (22.2 %) were removed out within 72 hours.
제1형 신경섬유종증 환자의 파열된 위십이지장동맥 동맥류에서 발생한 위중한 십이지장 궤양 출혈
임규성 ( Kyu Sung Im ),김선용 ( Sun Yong Kim ),임준욱 ( Jun Uk Lim ),전장원 ( Jung Won Jeon ),신현필 ( Hyun Phil Shin ),차재명 ( Jae Myung Cha ),주광로 ( Kwang Ro Joo ),이정일 ( Joung Ll Lee ),박재준(교신저자) ( Jae Jun Park ) 대한소화기학회 2015 대한소화기학회지 Vol.66 No.3
Vasculopathy is rarely reported in neurofibromatosis type 1, but when it occurs it primarily involves the aorta and its main branches. Among vasculopathies, aneurysmal dilatation is the most common form. Although several case reports concerning aneurysms or pseudoaneurysms of visceral arteries in neurofibromatosis type 1 patients have been reported, there are no reports describing gastroduodenal artery aneurysms associated with neurofibromatosis type 1. We experienced a case of life-threatening duodenal ulcer bleeding from a ruptured gastroduodenal artery aneurysm associated with neurofibromatosis type 1. We treated our patient by transarterial embolization after initial endoscopic hemostasis. To our knowledge, this is the first reported case of its type. High levels of suspicion and prompt diagnosis are required to select appropriate treatment options for patients with neurofibromatosis type 1 experiencing upper gastrointestinal bleeding. Embolization of the involved arteries should be considered an essential treatment over endoscopic hemostasis alone to achieve complete hemostasis and to prevent rebleeding. (Korean J Gastroenterol 2015;66:164-167)
복막 투석 환자에서 colistin으로 치료한 imipenem resistance Acinetobacter baumannii에 의한 복막염
임규성 ( Kyu Seong Lim ),박지나 ( Ji Na Pak ),문주영 ( Ju Young Moon ),정경환 ( Kyung Hwan Jeong ),이상호 ( Sang Ho Lee ),이태원 ( Tae Won Lee ),임천규 ( Chun Gyoo Ihm ),김명재 ( Myung Jae Kim ) 대한신장학회 2008 Kidney Research and Clinical Practice Vol.27 No.3
Peritonitis in continuous ambulatory peritoneal dialysis (CAPD) is a major cause of technical failure in peritoneal dialysis. The major pathogen is gram positive bacteria, and other main pathogens include gram negative bacteria, mixed microorganisms and fungi. The case of imipenem resistance Acinetobacter baumannii (IRAB) peritonitis are not common. We report a case of peritonitis by IRAB that was not responsive to the empirical antibiotics for CAPD-associated peritonitis. A 56-year-old male with a CAPD catheter inserted 2 weeks before visited our hospital for abdominal pain and turbid peritoneal fluid. He had been diagnosed as having an end stage renal disease (ESRD) about a month before. White blood cell and neutrophil count were elevated at the initial peritoneal fluid analysis, so we diagnosed him as having CAPD-associated peritonitis. Antibiotic therapy was initiated with intraperitoneal injections of ceftazidime/cefamezine which were soon changed to vancomycin/ceftazidime. However, vancomycin/ceftazidime regimen proved ineffective. On the fifth and sixth hospital day, IRAB was cultured from the CAPD catheter exit site swab and peritoneal fluid sampled on the first visiting day. Accordingly, we changed the antibiotics to colistin and removed the CAPD catheter, which led to clinical and laboratory improvement. In the cases of CAPD associated peritonitis in patients who have a history of ICU stay, exposure to the 3rd generation cephalosporin or imipenem, or who are elderly, we must suspect unusual pathogen or multi-drug resistance pathogen such as IRAB.
이의주,김윤영,임규성,김상복,이수경,고병희,조여원,송일병,Lee, Eui-ju,Kim, Yun-young,Lim, Kyu-seoug,Kim, Sang-bok,Lee, Su-kyung,Koh, Byung-hee,Cho, Yo-won,Song, Il-Byung 사상체질의학회 1999 사상체질의학회지 Vol.11 No.2
본 연구에서는 총 65명의 고지혈증환자를 대상으로 일반치료식과 체질치료식을 처방한 후 3주 후, 6주 후를 비교하여 그 효능을 비교하였다. 체질치료식은 영양학과 사상체질의학을 고려하여 구성되었다. 태음인의 경우를 살펴보면, 일반치료식과 체질치료식은 Serum Lipids의 항목에서 같은 수준으로 영향을 주었다. 일반치료식은 TC(6주후), TG(6주후)에서 유의한 감소(P<0.05)가 관찰되어 체질치료식보다 우수한 부분이 있었고, 체질치료식은 PL(6주후)에서 유의있는 감소(P<0.01) 가 관찰되어 일반치료식보다 우수하였다. 소양인의 경우를 살펴보면, 일반치료식에서는 변화가 없었으나 체질치료식에서는 TL(3주후 6주후), PL(3주후)에서 유의있는 감소(P<0.05)가 관찰되었다. In this study, we compared the effect of the Therapeutic Diet and Constitutional Diet on the subjects whose total number is 65 and has hyperlipidemia by checking the serum lipids 3weeks later, 6weeks later. In the Taeumin, there is a little difference in the two Dietary Therapies. Therapeutic Diet shows significant decrease in the total-cholesterol(6weeks later), triglyceride(6weeks later). (P<0.05) In that point Therapeutic Diet shows better effect than Constitutional Diet. Constitutional Diet shows better effect in the phospholipid by significant decrease in the phospholipid(6weeks later).(P<0.01) In the Soyangin group, Therapeutic Diet shows no difference, but Constitutional Diet shows significant decrease in the total lipid(3weeks, 6weeks later), phospholipid(3weeks later).(P<0.05).
간세포암종 환자에서 TNM, Okuda, CLIP, JIS, BCLC 병기설정에 따른 예후 분별 능력의 비교
구혜영(Hye Young Koo),권성원(Sung Won Kwon),이화영(Hwa Young Lee),황성규(Sung Kyu Hwang),임규성(Kyu Sung Lim),김만득(Man Deuk Kim) 한국간담췌외과학회 2010 한국간담췌외과학회지 Vol.14 No.1
Purpose: There is yet no ideal single staging system for hepatocellular carcinoma (HCC). The aim of this study was to analyze HCC survival times according to the TNM, Okuda, CLIP, JIS, and BCLC staging systems and their prognostic discrimination ability. Methods: A retrospective analysis of medical records and statistical data from the Korean statistical information service was done for HCC patients diagnosed at Bundang CHA hospital between June, 1992 and February, 2009. Results: During follow-up, 121 (72%) of 168 people died and 1, 3 and 5 year overall survival rates were, respectively, 58%, 35% and 25%. In the analysis of discriminative ability of each staging system, the CLIP staging system showed the highest LR X2 value, and the lowest AIC value (p<0.05). Therefore, the CLIP staging system appears to be superior to the other systems. Conclusion: Of the 5 staging systems in this study, the CLIP staging system was superior to the other systems, but the results of many other studies from different countries have varied. It is necessary to establish the staging system suitable for each country’s actual circumstances.
만성 B 형 간염환자에서 알파 인터페론의 용량에 따른 치료 효과
최예원(Ye Weon Choi),박승욱(Seung Wook Park),김규태(Kyu Tae Kim),조호준(Ho Jun Cho),고순희(Soon Hee Ko),김동규(Dong Kyu Kim),신호균(Ho Kyun Shin),김학양(Hak Yang Kim),박충기(Choong Kee Park),임규성(Kyu Sung Lim),유재영(Jae Young Yoo) 대한내과학회 1991 대한내과학회지 Vol.41 No.1
To assess the effect of different dosages of interferon alpha-2b(Intron A), 43 patients with chronic hepatitis B were assigned randomly to 3 groups: Group A, l5 patients, received Intron A in a dose of 3 million units (MU) thrice weekly for 12 weeks (total dosage: 1.8×108); Group B, 14 patients, received in a dose of 3 MU every day for the first month and thereafter every other day for the following 4 months (total dosage: 2.7×108); Group C, 14 patients, received no specific therapy. They included 34 men and 9 women, between 17 to 53 (mean 35) years of ages, with elevated serum AST and ALT levels; 41 to 879 (mean 289), and 57 to 334 (mean 288)U/L, respectively. Needle biopsies of the liver before therapy revealed chronic active hepatitis in 35 cases and active cirrhosis in 7 cases, The average follow-up period was 12 months. The results were as follows; 1) During the therapy, serum ALT levels returned to normal in 12 (80%) of Group A and in 12 (86%) of Group B, but increased again in 8 out of 12 in Group A, and in 4 out of 12 in Group B during the follow-up period, In Group C, the ALT level returned to normal in 3 out of 15 during the same period. 2) Serum HBeAg became negative in 6 out of group A in 11 out of Group B, but became positive again in 2 out of 6 in Group A and in 3 out of 11 in Group B during the follow-up period; The sero-negative conversion rate of HBeAg at the end of this study was 27 in Group A and 57% in Group B. In Group C, the sero-conversion of HBeAg was found in 2 out of 14 (14%). A statistically significant difference was noted between Group B and Group C (p<0.05). 3) Comparison of responders and non-responders in the treated group showed no differences in age, sex, liver fuction test, and tissue pathology. 4) Although flu-like symptoms (100%), loss of hair l (10%), and leukopenia (40%) were observed in the treated group, no serious side effects necessitating discontinuation of the therapy were observed. In conclusion, this study showed that the effect of interferon on patients with chronic hepatitis B might be different depending on the dosage and duration of therapy and that with increased dosage, the response rate could to be higher. But further studies should be carried out to determine the exact duration and dosage of therapy in these patients.
양재식(Jea Sik Yang),이명구(Myung Goo Lee),임현석(Hyun Suk Lim),김우중(Yoo Joung Kim),박충기(Choong Kee Park),임규성(Kyu Sung Rim) 대한내과학회 1988 대한내과학회지 Vol.34 No.2
N/A The usefulness of EPT, to remove biliary atone is widely approved. So we reporters are willing to investigate and report 39 cases of EPT. out of 420 cases of ERCP performed from September 1983, to April 1987 in Kangnam Sacred Heart Hospital, Seoul, Korea. The results are as follows: 1) The distribution of age was from 24 year to 77 year old, and the sixties were 15 cases (37.7%), the most. The difference of sex could be disregarded; 18 men and 20 women. 2) The histories of cholecystectomy were found in 20 cases out of 39 ones. 3) There were the stones in 38 cases out of 39 cases: The most frequent site was common bile duct in 21 cases. 4) Out of 32 ca of the first EPT. (1) In 6 ca stones were confirmed in stool. (2) In 7 cases stones were confirmed in basket extraction and natural passing at EPT. (3) In 17 cases stones extraction were confirmed at second ERCP, & the improvement of clinical & laboratory. (4) 2 cases were not followed-up. 5) Out of 6 cases failed at first EPT, 2 cases were impacted stones, and managed by operation, 3 cases were incomp1ete excision; we succed at second performance. 1 case was very large stone (6×2×2); we succed in passing the stone at third performance by lithotripsy without significant complication. 6) Size of the removed stones was 0.5 cm to 6 cm. Lots of stones were 1.5 cm to 2.5 cm(12 cases-31.6%) and in 2 cases the stones were over 5 cm. 7) After EPT, it's complication was found in 4 cases (10.5%): in 2 cases transfusion was demanded because of bleeding; in 2 cases operation was performed because of impacted stone.